On June 30, 2022, Bridge Biotherapeutics, Inc. closed the transaction. The company issued 292,680 shares for gross proceeds of KRW 2,999,970,000 in the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,220 KRW | +1.60% | -3.69% | -32.42% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
6,810 KRW | -2.01% | -3.13% | 78.56M | ||
3,365 KRW | -1.17% | +1.82% | 555M | ||
2,220 KRW | +1.60% | -3.69% | 40M | ||
2,040 KRW | -2.16% | -1.45% | 80.26M | ||
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.42% | 40M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- A288330 Stock
- News Bridge Biotherapeutics, Inc.
- Bridge Biotherapeutics, Inc. announced that it has received KRW 2.99997 billion in funding from a group of investors